Tectonic Therapeutic | AVRO - Loan Capital


Tectonic Therapeutic reported $17K in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
Akebia Therapeutics USD 24.75M 11.64M Jun/2026
Alnylam Pharmaceuticals USD 2.47B 6.56M Jun/2026
Celltrion KRW 411.27B 998.23M Mar/2026
Cspc Pharmaceutical CNY 180.69M 21.94M Dec/2025
Deva Holding AS TRY 559.97M 44.39M Sep/2023
Dianthus Therapeutics USD 0 0 Dec/2024
Divis Laboratories Ltd INR 50M 30M Mar/2026
Gilead Sciences USD 20.86B 1.27B Mar/2026
Ionis Pharmaceuticals USD 1.91B 6.62M Jun/2026
Kangmei Pharma CNY 68.57M 9.87M Mar/2026
Karyopharm Therapeutics USD 264.49M 13.73M Mar/2026
Knight Therapeutics CAD 57.78M 26.92M Dec/2025
Laboratorios Farma EUR 80.5M 28.26M Dec/2024
MacroGenics USD 68.71M 1.29M Mar/2026
Malin Corporation EUR 0 0 Dec/2024
Medical Developments International AUD 1.5M 167K Dec/2025
Organigram Holdings CAD 60.76M 1.77M Mar/2026
Ovoca Bio EUR 0 0 Jun/2021
Pfizer USD 60.5B 70M Jun/2026
Pharma Mar EUR 32.13M 1.04M Jun/2026
Qiagen NV USD 1.63B 19.45M Jun/2026
Roche Holding CHF 25.22B 2.21B Jun/2026
Sangamo BioSciences USD 0 0 Jun/2022
Sanofi EUR 14.65B 806M Jun/2026
Sarepta Therapeutics USD 847.62M 9.46M Jun/2026
Sartorius EUR 3.65B 311.1M Jun/2026
Sino Biopharmaceutical CNY 3.08B 1B Jun/2025
Takeda JPY 4.42T 50.32B Jun/2026
Tilray USD 268.59M 3.82M Sep/2025
Zealand Pharma A/S 307M 76.14M Mar/2026
Zz Pientze Pharmaceu CNY 172.8M 9.49M Jun/2026